Recall of Device Recall Viscocel and Viscocel Plus

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by C.L.R. Medicals International, Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    66930
  • Event Risk Class
    Class 1
  • Event Number
    Z-0531-2014
  • Event Initiated Date
    2013-11-25
  • Event Date Posted
    2013-12-20
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2014-12-05
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Aid, surgical, viscoelastic - Product Code LZP
  • Reason
    Clr medicals international inc., initiated a nationwide recall of viscocel and viscocel plus, in response to fda inspection findings of deficiencies in the quality system regulations for medical device manufacturers, 21 code of federal regulation (cfr) part 820 and lack of premarket approval (pma) for devices sold or distributed in domestic commerce. the viscoelastic products, intended for human.
  • Action
    CLR Medicals initiated a nationwide recall on November 25, 2013, of Viscocel and Viscocel Plus, by issuing a press release,in response to FDA inspectional findings of deficiencies in the Quality System regulations for Medical Device Manufacturers, 21 Code of Federal Regulation (CFR) Part 820 and lack of Premarket Approval (PMA) for devices sold or distributed in domestic commerce. The Viscoelastic products, intended for human and animal use, have been determined to be a public health concern due to distribution in the US without FDA approval, which evaluates the safety and efficacy of the product, and violations of the QSR regulations related to sterility, and biocompatibility that may result in the release of contaminated products. CLR Medicals International, Inc. sent a Medical Device Recall letter dated December 6, 2013, to all affected customers. The letter informed customers of the reason for recall, product description with manufacturing date range, possible health hazard, instructions on what to do with recalled product, and contact information for the firm and to report any adverse events to FDA MedWatch. The recall notification letter was accompanied by a response form. Customers with questions were instructed to call 909-398-1880. For questions regarding this recall call 909-398-1880.

Device

  • Model / Serial
    All lots manufactured September 01, 2011 to September 19, 2013.
  • Product Classification
  • Device Class
    3
  • Implanted device?
    No
  • Distribution
    Worldwide Distribution - USA (nationwide) and Internationally to Egypt, Mexico, and Canada.
  • Product Description
    Viscocel and Viscocel Plus. || These products are intraocular fluid devices consisting of non-gaseous fluid intended to be introduced into the eye to aid performance of surgery, such as to maintain anterior chamber depth, preserve tissue integrity, protect tissue from surgical trauma, or function as a tamponade during retinal reattachment.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    C.L.R. Medicals International, Inc., 748 E Bonita Ave Ste 210, Pomona CA 91767-1922
  • Manufacturer Parent Company (2017)
  • Source
    USFDA